Yanghae Park

Title: Innovations of Yanghae Park

Introduction

Yanghae Park is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals through his innovative research and development. His work focuses on novel compounds that have the potential to treat various medical conditions.

Latest Patents

Yanghae Park holds a patent for a compound titled "Salt of 2-amino-2-(2-(1-decyl-1H-1,2,3-triazol-4-yl)ethyl)propane-1,3-diol, and pharmaceutical composition containing same." This invention relates to a novel salt that exhibits excellent properties such as low hygroscopicity, stability, and solubility. The pharmaceutical composition containing this novel salt can be effectively used for preventing or treating multiple sclerosis, ischemic stroke, focal segmental glomerulosclerosis (FSGS), inflammatory bowel disease, interstitial fibrosis and tubular atrophy (IFTA), and alopecia areata (AA). Yanghae Park has 1 patent to his name.

Career Highlights

Yanghae Park is currently associated with Nextgen Bioscience Co., Ltd., where he continues to innovate in the pharmaceutical sector. His research has led to advancements that could significantly impact the treatment of serious health conditions.

Collaborations

He collaborates with talented individuals such as Bongyong Lee and Eunjeong Kim, contributing to a dynamic research environment that fosters innovation.

Conclusion

Yanghae Park's contributions to pharmaceutical innovations highlight his role as a key inventor in the field. His work not only advances scientific knowledge but also has the potential to improve patient outcomes in various medical conditions.